Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 224 entries
Sorted by: Best Match Show Resources per page
Dual-beam manually-actuated distortion-corrected imaging (DMDI) with micromotor catheters.

Optics express

Lee AMD, Hohert G, Angkiriwang PT, MacAulay C, Lane P.
PMID: 29041505
Opt Express. 2017 Sep 04;25(18):22164-22177. doi: 10.1364/OE.25.022164.

We present a new paradigm for performing two-dimensional scanning called dual-beam manually-actuated distortion-corrected imaging (DMDI). DMDI operates by imaging the same object with two spatially-separated beams that are being mechanically scanned rapidly in one dimension with slower manual actuation...

Cite
Lee AMD, Hohert G, Angkiriwang PT, et al. Dual-beam manually-actuated distortion-corrected imaging (DMDI) with micromotor catheters. Opt Express. 2017;25(18):22164-22177doi: 10.1364/OE.25.022164.
Lee, A. M. D., Hohert, G., Angkiriwang, P. T., MacAulay, C., & Lane, P. (2017). Dual-beam manually-actuated distortion-corrected imaging (DMDI) with micromotor catheters. Optics express, 25(18), 22164-22177. https://doi.org/10.1364/OE.25.022164
Lee, Anthony M D, et al. "Dual-beam manually-actuated distortion-corrected imaging (DMDI) with micromotor catheters." Optics express vol. 25,18 (2017): 22164-22177. doi: https://doi.org/10.1364/OE.25.022164
Lee AMD, Hohert G, Angkiriwang PT, MacAulay C, Lane P. Dual-beam manually-actuated distortion-corrected imaging (DMDI) with micromotor catheters. Opt Express. 2017 Sep 04;25(18):22164-22177. doi: 10.1364/OE.25.022164. PMID: 29041505.
Copy Download .nbib Format: NLM
Application of A 'Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Macaulay R.
PMID: 27201153
Value Health. 2014 Nov;17(7):A436. doi: 10.1016/j.jval.2014.08.1127. Epub 2014 Oct 26.

No abstract available.

Cite
Macaulay R. Application of A 'Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process. Value Health. 2014;17(7):A436doi: 10.1016/j.jval.2014.08.1127.
Macaulay, R. (2014). Application of A 'Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A436. https://doi.org/10.1016/j.jval.2014.08.1127
Macaulay, R. "Application of A 'Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A436. doi: https://doi.org/10.1016/j.jval.2014.08.1127
Macaulay R. Application of A 'Nice Post-Hoc B/S Analysis' To the Nice Appraisal Process. Value Health. 2014 Nov;17(7):A436. doi: 10.1016/j.jval.2014.08.1127. Epub 2014 Oct 26. PMID: 27201153.
Copy Download .nbib Format: NLM
Reproducibility of optical coherence tomography airway imaging.

Biomedical optics express

Kirby M, Ohtani K, Nickens T, Lisbona RM, Lee AM, Shaipanich T, Lane P, MacAulay C, Lam S, Coxson HO.
PMID: 26601002
Biomed Opt Express. 2015 Oct 14;6(11):4365-77. doi: 10.1364/BOE.6.004365. eCollection 2015 Nov 01.

Optical coherence tomography (OCT) is a promising imaging technique to evaluate small airway remodeling. However, the short-term insertion-reinsertion reproducibility of OCT for evaluating the same bronchial pathway has yet to be established. We evaluated 74 OCT data sets from...

Cite
Kirby M, Ohtani K, Nickens T, et al. Reproducibility of optical coherence tomography airway imaging. Biomed Opt Express. 2015;6(11):4365-77doi: 10.1364/BOE.6.004365.
Kirby, M., Ohtani, K., Nickens, T., Lisbona, R. M., Lee, A. M., Shaipanich, T., Lane, P., MacAulay, C., Lam, S., & Coxson, H. O. (2015). Reproducibility of optical coherence tomography airway imaging. Biomedical optics express, 6(11), 4365-77. https://doi.org/10.1364/BOE.6.004365
Kirby, Miranda, et al. "Reproducibility of optical coherence tomography airway imaging." Biomedical optics express vol. 6,11 (2015): 4365-77. doi: https://doi.org/10.1364/BOE.6.004365
Kirby M, Ohtani K, Nickens T, Lisbona RM, Lee AM, Shaipanich T, Lane P, MacAulay C, Lam S, Coxson HO. Reproducibility of optical coherence tomography airway imaging. Biomed Opt Express. 2015 Oct 14;6(11):4365-77. doi: 10.1364/BOE.6.004365. eCollection 2015 Nov 01. PMID: 26601002; PMCID: PMC4646546.
Copy Download .nbib Format: NLM
Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Macaulay R.
PMID: 27202382
Value Health. 2014 Nov;17(7):A657. doi: 10.1016/j.jval.2014.08.2401. Epub 2014 Oct 26.

No abstract available.

Cite
Macaulay R. Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests. Value Health. 2014;17(7):A657doi: 10.1016/j.jval.2014.08.2401.
Macaulay, R. (2014). Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A657. https://doi.org/10.1016/j.jval.2014.08.2401
Macaulay, R. "Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A657. doi: https://doi.org/10.1016/j.jval.2014.08.2401
Macaulay R. Evidence for Regional Variation in the Appraisal of Individual Cancer Drugs Fund Requests. Value Health. 2014 Nov;17(7):A657. doi: 10.1016/j.jval.2014.08.2401. Epub 2014 Oct 26. PMID: 27202382.
Copy Download .nbib Format: NLM
Comparing Access to Drugs Through the CDF and by Nice - The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Macaulay R.
PMID: 27202392
Value Health. 2014 Nov;17(7):A659-60. doi: 10.1016/j.jval.2014.08.2415. Epub 2014 Oct 26.

No abstract available.

Cite
Macaulay R. Comparing Access to Drugs Through the CDF and by Nice - The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage. Value Health. 2014;17(7):A659-60doi: 10.1016/j.jval.2014.08.2415.
Macaulay, R. (2014). Comparing Access to Drugs Through the CDF and by Nice - The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A659-60. https://doi.org/10.1016/j.jval.2014.08.2415
Macaulay, R. "Comparing Access to Drugs Through the CDF and by Nice - The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A659-60. doi: https://doi.org/10.1016/j.jval.2014.08.2415
Macaulay R. Comparing Access to Drugs Through the CDF and by Nice - The CDF Stipulate Stricter Clinical Criteria but will Also Approve Funding for Off-Label Usage. Value Health. 2014 Nov;17(7):A659-60. doi: 10.1016/j.jval.2014.08.2415. Epub 2014 Oct 26. PMID: 27202392.
Copy Download .nbib Format: NLM
Dehydrogenative B-H/C(sp.

Angewandte Chemie (International ed. in English)

Kelly CM, Fuller JT, Macaulay CM, McDonald R, Ferguson MJ, Bischof SM, Sydora OL, Ess DH, Stradiotto M, Turculet L.
PMID: 28370808
Angew Chem Int Ed Engl. 2017 May 22;56(22):6312-6316. doi: 10.1002/anie.201700857. Epub 2017 Mar 30.

The first examples of stoichiometric dehydrogenative B-H/C(sp

Cite
Kelly CM, Fuller JT, Macaulay CM, et al. Dehydrogenative B-H/C(sp. Angew Chem Int Ed Engl. 2017;56(22):6312-6316doi: 10.1002/anie.201700857.
Kelly, C. M., Fuller, J. T., Macaulay, C. M., McDonald, R., Ferguson, M. J., Bischof, S. M., Sydora, O. L., Ess, D. H., Stradiotto, M., & Turculet, L. (2017). Dehydrogenative B-H/C(sp. Angewandte Chemie (International ed. in English), 56(22), 6312-6316. https://doi.org/10.1002/anie.201700857
Kelly, Colin M, et al. "Dehydrogenative B-H/C(sp." Angewandte Chemie (International ed. in English) vol. 56,22 (2017): 6312-6316. doi: https://doi.org/10.1002/anie.201700857
Kelly CM, Fuller JT, Macaulay CM, McDonald R, Ferguson MJ, Bischof SM, Sydora OL, Ess DH, Stradiotto M, Turculet L. Dehydrogenative B-H/C(sp. Angew Chem Int Ed Engl. 2017 May 22;56(22):6312-6316. doi: 10.1002/anie.201700857. Epub 2017 Mar 30. PMID: 28370808.
Copy Download .nbib Format: NLM
Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units.

The Canadian journal of hospital pharmacy

Slaney H, MacAulay S, Irvine-Meek J, Murray J.
PMID: 26157183
Can J Hosp Pharm. 2015 May-Jun;68(3):218-25. doi: 10.4212/cjhp.v68i3.1455.

BACKGROUND: The Beers criteria were developed to help in identifying potentially inappropriate medications (PIMs) for elderly patients. These medications are often associated with adverse events and limited effectiveness in older adults. Patients awaiting an alternate level of care (ALC...

Cite
Slaney H, MacAulay S, Irvine-Meek J, et al. Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units. Can J Hosp Pharm. 2015;68(3):218-25doi: 10.4212/cjhp.v68i3.1455.
Slaney, H., MacAulay, S., Irvine-Meek, J., & Murray, J. (2015). Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units. The Canadian journal of hospital pharmacy, 68(3), 218-25. https://doi.org/10.4212/cjhp.v68i3.1455
Slaney, Heather, et al. "Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units." The Canadian journal of hospital pharmacy vol. 68,3 (2015): 218-25. doi: https://doi.org/10.4212/cjhp.v68i3.1455
Slaney H, MacAulay S, Irvine-Meek J, Murray J. Application of the Beers Criteria to Alternate Level of Care Patients in Hospital Inpatient Units. Can J Hosp Pharm. 2015 May-Jun;68(3):218-25. doi: 10.4212/cjhp.v68i3.1455. PMID: 26157183; PMCID: PMC4485509.
Copy Download .nbib Format: NLM
Diagnostic facilities for general practitioners.

Lancet (London, England)

MACAULAY HM.
PMID: 14467734
Lancet. 1962 Apr 14;1(7233):791-3. doi: 10.1016/s0140-6736(62)91803-2.

No abstract available.

Cite
MACAULAY HM. Diagnostic facilities for general practitioners. Lancet. 1962;1(7233):791-3doi: 10.1016/s0140-6736(62)91803-2.
MACAULAY, H. M. (1962). Diagnostic facilities for general practitioners. Lancet (London, England), 1(7233), 791-3. https://doi.org/10.1016/s0140-6736(62)91803-2
MACAULAY, H M. "Diagnostic facilities for general practitioners." Lancet (London, England) vol. 1,7233 (1962): 791-3. doi: https://doi.org/10.1016/s0140-6736(62)91803-2
MACAULAY HM. Diagnostic facilities for general practitioners. Lancet. 1962 Apr 14;1(7233):791-3. doi: 10.1016/s0140-6736(62)91803-2. PMID: 14467734.
Copy Download .nbib Format: NLM
Multispectral digital microscopy for in vivo monitoring of oral neoplasia in the hamster cheek pouch model of carcinogenesis.

Optics express

Park SY, Collier T, Aaron J, Markey M, Richards-Kortum R, Sokolov K, Mackinnon N, Macaulay C, Coghlan L, Milbourne A, Follen M.
PMID: 19494935
Opt Express. 2005 Feb 07;13(3):749-62. doi: 10.1364/opex.13.000749.

In this study we use a multi-spectral digital microscope (MDM) to measure multi-spectral auto-fluorescence and reflectance images of the hamster cheek pouch model of DMBA (dimethylbenz[alpha]anthracene)- induced oral carcinogenesis. The multi-spectral images are analyzed both in the RGB (red,...

Cite
Park SY, Collier T, Aaron J, et al. Multispectral digital microscopy for in vivo monitoring of oral neoplasia in the hamster cheek pouch model of carcinogenesis. Opt Express. 2005;13(3):749-62doi: 10.1364/opex.13.000749.
Park, S. Y., Collier, T., Aaron, J., Markey, M., Richards-Kortum, R., Sokolov, K., Mackinnon, N., Macaulay, C., Coghlan, L., Milbourne, A., & Follen, M. (2005). Multispectral digital microscopy for in vivo monitoring of oral neoplasia in the hamster cheek pouch model of carcinogenesis. Optics express, 13(3), 749-62. https://doi.org/10.1364/opex.13.000749
Park, Sun Young, et al. "Multispectral digital microscopy for in vivo monitoring of oral neoplasia in the hamster cheek pouch model of carcinogenesis." Optics express vol. 13,3 (2005): 749-62. doi: https://doi.org/10.1364/opex.13.000749
Park SY, Collier T, Aaron J, Markey M, Richards-Kortum R, Sokolov K, Mackinnon N, Macaulay C, Coghlan L, Milbourne A, Follen M. Multispectral digital microscopy for in vivo monitoring of oral neoplasia in the hamster cheek pouch model of carcinogenesis. Opt Express. 2005 Feb 07;13(3):749-62. doi: 10.1364/opex.13.000749. PMID: 19494935.
Copy Download .nbib Format: NLM
Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling.

Biomarker insights

Kneller JM, Ehlen T, Matisic JP, Miller D, Van Niekerk D, Lam WL, Marra M, Richards-Kortum R, Follen M, Macaulay C, Jones SJ.
PMID: 19662225
Biomark Insights. 2007 Dec 11;2:447-61.

Sixteen longSAGE libraries from four different clinical stages of cervical intraepithelial neoplasia have enabled us to identify novel cell-surface biomarkers indicative of CIN stage. By comparing gene expression profiles of cervical tissue at early and advanced stages of CIN,...

Cite
Kneller JM, Ehlen T, Matisic JP, et al. Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling. Biomark Insights. 2007;2:447-61
Kneller, J. M., Ehlen, T., Matisic, J. P., Miller, D., Van Niekerk, D., Lam, W. L., Marra, M., Richards-Kortum, R., Follen, M., Macaulay, C., & Jones, S. J. (2007). Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling. Biomarker insights, 2447-61.
Kneller, Julie M, et al. "Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling." Biomarker insights vol. 2 (2007): 447-61.
Kneller JM, Ehlen T, Matisic JP, Miller D, Van Niekerk D, Lam WL, Marra M, Richards-Kortum R, Follen M, Macaulay C, Jones SJ. Using LongSAGE to Detect Biomarkers of Cervical Cancer Potentially Amenable to Optical Contrast Agent Labelling. Biomark Insights. 2007 Dec 11;2:447-61. PMID: 19662225; PMCID: PMC2717845.
Copy Download .nbib Format: NLM
Immunosenescence and Cytomegalovirus: where do we stand after a decade?.

Immunity & ageing : I & A

Pawelec G, Akbar A, Beverley P, Caruso C, Derhovanessian E, Fülöp T, Griffiths P, Grubeck-Loebenstein B, Hamprecht K, Jahn G, Kern F, Koch SD, Larbi A, Maier AB, Macallan D, Moss P, Samson S, Strindhall J, Trannoy E, Wills M.
PMID: 20822513
Immun Ageing. 2010 Sep 07;7:13. doi: 10.1186/1742-4933-7-13.

No abstract available.

Cite
Pawelec G, Akbar A, Beverley P, et al. Immunosenescence and Cytomegalovirus: where do we stand after a decade?. Immun Ageing. 2010;7:13doi: 10.1186/1742-4933-7-13.
Pawelec, G., Akbar, A., Beverley, P., Caruso, C., Derhovanessian, E., Fülöp, T., Griffiths, P., Grubeck-Loebenstein, B., Hamprecht, K., Jahn, G., Kern, F., Koch, S. D., Larbi, A., Maier, A. B., Macallan, D., Moss, P., Samson, S., Strindhall, J., Trannoy, E., & Wills, M. (2010). Immunosenescence and Cytomegalovirus: where do we stand after a decade?. Immunity & ageing : I & A, 713. https://doi.org/10.1186/1742-4933-7-13
Pawelec, Graham, et al. "Immunosenescence and Cytomegalovirus: where do we stand after a decade?." Immunity & ageing : I & A vol. 7 (2010): 13. doi: https://doi.org/10.1186/1742-4933-7-13
Pawelec G, Akbar A, Beverley P, Caruso C, Derhovanessian E, Fülöp T, Griffiths P, Grubeck-Loebenstein B, Hamprecht K, Jahn G, Kern F, Koch SD, Larbi A, Maier AB, Macallan D, Moss P, Samson S, Strindhall J, Trannoy E, Wills M. Immunosenescence and Cytomegalovirus: where do we stand after a decade?. Immun Ageing. 2010 Sep 07;7:13. doi: 10.1186/1742-4933-7-13. PMID: 20822513; PMCID: PMC2939591.
Copy Download .nbib Format: NLM
Assessing the benefits of participatory research: a rationale for a realist review.

Global health promotion

Macaulay AC, Jagosh J, Seller R, Henderson J, Cargo M, Greenhalgh T, Wong G, Salsberg J, Green LW, Herbert CP, Pluye P.
PMID: 21744664
Glob Health Promot. 2011 Jun;18(2):45-8. doi: 10.1177/1757975910383936.

Participatory research (PR) experts believe that increased community and stakeholder participation in research augments program pertinence, quality, outcome, sustainability, uptake, and transferability. There is, however, a dearth of assessments and measurement tools to demonstrate the contribution of participation in...

Cite
Macaulay AC, Jagosh J, Seller R, et al. Assessing the benefits of participatory research: a rationale for a realist review. Glob Health Promot. 2011;18(2):45-8doi: 10.1177/1757975910383936.
Macaulay, A. C., Jagosh, J., Seller, R., Henderson, J., Cargo, M., Greenhalgh, T., Wong, G., Salsberg, J., Green, L. W., Herbert, C. P., & Pluye, P. (2011). Assessing the benefits of participatory research: a rationale for a realist review. Global health promotion, 18(2), 45-8. https://doi.org/10.1177/1757975910383936
Macaulay, Ann C, et al. "Assessing the benefits of participatory research: a rationale for a realist review." Global health promotion vol. 18,2 (2011): 45-8. doi: https://doi.org/10.1177/1757975910383936
Macaulay AC, Jagosh J, Seller R, Henderson J, Cargo M, Greenhalgh T, Wong G, Salsberg J, Green LW, Herbert CP, Pluye P. Assessing the benefits of participatory research: a rationale for a realist review. Glob Health Promot. 2011 Jun;18(2):45-8. doi: 10.1177/1757975910383936. PMID: 21744664.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 224 entries